BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211102T090000
DTEND;TZID=Europe/Stockholm:20211102T100000
DTSTAMP:20260405T183836
CREATED:20210902T060701Z
LAST-MODIFIED:20211019T152930Z
UID:10000425-1635843600-1635847200@www.scilifelab.se
SUMMARY:BioImage Informatics Call4Help Webinar: CellPose
DESCRIPTION:For our next Call4Help session we are organizing a tool-presentation seminar about CellPose\, a generalist algorithm for cell and nuclei segmentation. CellPose is a deep learning-based segmentation method trained on a wide range of image types. It can be applied to both 2D and 3D images.  \n\n\n\nDuring this seminar we will explore different ways to run CellPose\, including demos powered by the ImJoy server which aim to make it easier for users to analyse large datasets in computing clusters. The webinar will be given by Gisele Miranda (BIIF) and Wei Ouyang (KTH\, developer of ImJoy) and will take place on November 2nd\, 09:00-10:00. There will be time for questions and discussion\, so we hope this event to be very interactive. Please register here. \n\n\n\nregistration\n\n\n\nImportant links\n\n\n\nhttps://github.com/MouseLand/cellposehttps://imjoy.io/
URL:https://www.scilifelab.se/event/bioimage-informatics-call4help-5/
CATEGORIES:Event
ORGANIZER;CN="Bioimage Informatics Unit":MAILTO:biif@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211103T151500
DTEND;TZID=Europe/Stockholm:20211103T164500
DTSTAMP:20260405T183836
CREATED:20211021T083636Z
LAST-MODIFIED:20211027T132303Z
UID:10000472-1635952500-1635957900@www.scilifelab.se
SUMMARY:SciLifeLab COVID-19 seminars: Lars Juhl Jensen and Sonja Aits
DESCRIPTION:The fourth seminar in this series starts with Lars Juhl Jensen\, Professor\, Novo Nordisk Foundation Center for Protein Research\, Faculty of Health and Medical Sciences\, University of Copenhagen\, who will talk about From intraspecies protein networks to host–pathogen networks.  \n\n\n\nSonja Aits\, Associate senior lecturer at Cell Death\, Lysosomes and Artificial Intelligence\, Lund University\, then continues the seminar with a talk on Text mining for COVID-19 knowledge extraction \n\n\n\n\n\n\n\n Registration is mandatory to get the Zoom link for the event  \n\n\n\n\nREGISTRATION\n\n\n\nBIOS & ABSTRACTS
URL:https://www.scilifelab.se/event/scilifelab-covid-19-seminars-lars-juhl-jensen-and-sonja-aits/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211108T093000
DTEND;TZID=Europe/Stockholm:20211108T103000
DTSTAMP:20260405T183836
CREATED:20210609T090521Z
LAST-MODIFIED:20210826T100254Z
UID:10000400-1636363800-1636367400@www.scilifelab.se
SUMMARY:Career path discussions with Jennifer Lippincott-Schwartz
DESCRIPTION:Jennifer Lippincott-Schwartz from the Howard Hughes Medical Institute will give an account of her career path and discuss with students and postdocs at 09.30 in the SciLifeLab Air&Fire auditorium. Since the number of places is limited\, please register below to participate in this session. \n\n\n\n\n\n\n\nRegister\n\n\n\n\n\n\n\nUsing cutting-edge\, superresolution imaging technology to visualize cellular activity at the nano-scale\, Lippincott-Schwartz lab has redefined how we look at protein dynamics in the cell. When describing her mentorship philosophy\, Jennifer comments that she encourages her group members to develop their own projects. It is only when a colleague feels that he or she “owns” the project that real dedication\, determination\, and creativity emerge. In developing projects\, she considers it is important to build on the strengths and interests of students and postdocs\, rather than focusing exclusively on a group leader’s specific interests at the time. \n\n\n\nThe annual lecture series is set up in the recognition of the development of electron microscopy and will be delivered by eminent scientists in the field of structural biology and molecular visualisation. The event is open to anyone. The main lecture will take place at 4.00pm in the Biomedicum Lecture Theatre. \n\n\n\nContact \n\n\n\nAlexey Amunts\, amunts@scilifelab.se
URL:https://www.scilifelab.se/event/career-path-discussions-with-jennifer-lippincott-schwartz/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211108T151500
DTEND;TZID=Europe/Stockholm:20211108T163000
DTSTAMP:20260405T183836
CREATED:20211005T080424Z
LAST-MODIFIED:20211005T080541Z
UID:10000460-1636384500-1636389000@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Ass. Prof. Maria Kasper
DESCRIPTION:Karolinska Institutet\, Department of Cell and Molecular Biology\, Sweden \n\n\n\nLINK TO SEMINAR   \n\n\n\n\n\n\n\n\n\nMaria Kasper is Associate Professor at the Karolinska Institutet in Stockholm\, Department of Cell and Molecular Biology. She received her PhD at the University of Salzburg in genetics\, with the majors in human genetics and molecular tumor biology. She came to Sweden in 2007\, where she spent a fruitful postdoctoral time in Rune Toftgårds lab\, and in 2013 she started her own lab focusing on skin\, stem cell biology and single-cell RNA sequencing. In 2016\, her lab pioneered the use of single-cell transcriptomics in the organ skin and has overall contributed with important work in skin biology and regenerative medicine. Maria has received a number of national recognitions such as the Framtidens Forskningsledare from SSF\, Ragnar Söderberg Fellow in Medicine and the CIMED young investigator award\, as well as the prestigious international LEO Foundation Gold Award for outstanding skin research. Since 2020\, she also coordinates together with Fiona Watt the Human Cell Atlas bionetwork for the organ skin. \n\n\n\nDecoding the molecular anatomy of skin\n\n\n\nSkin architecture and its function are determined by a rich variety of epithelial\, mesenchymal and immune cells that together orchestrate skin homeostasis\, including cyclical hair growth and barrier function. Previously\, my lab generated a comprehensive molecular and spatial atlas of epithelial and stromal cells during hair growth and rest. These studies revealed underlying molecular programs during progenitor-cell commitment and lineage differentiation\, as well as spatiotemporal fibroblast heterogeneity and potential epithelial-stromal interactions. The importance of cell-type specific signaling during homeostasis\, and the unrecognized potential of cell-type restricted signaling-changes were exemplified by our recent discovery of how to induce new hair follicles in adult mouse skin by modulating a single signaling pathway. Building on the molecular knowledge and computational skills gained\, our ongoing work uncovers new insights in the molecular orchestration of embryonic hair follicle development\, as well as the coordination of adult skin stem cell differentiation by tissue resident immune cells.Host: Gabriella Lindgren\, SLU
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-ass-prof-maria-kasper/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211108T160000
DTEND;TZID=Europe/Stockholm:20211108T170000
DTSTAMP:20260405T183836
CREATED:20210609T090256Z
LAST-MODIFIED:20210826T100440Z
UID:10000399-1636387200-1636390800@www.scilifelab.se
SUMMARY:Annual lecture in structural biology by Jennifer Lippincott-Schwartz
DESCRIPTION:Jennifer Lippincott-Schwartz from the Howard Hughes Medical Institute will give the lecture entitled ‘Emerging Imaging Technologies to Study Cell Architecture\, Dynamics\, and Function’ on November 8\, 2021 at 4.00pm in the Biomedicum lecture theatre. Using cutting-edge\, superresolution imaging technology to visualize cellular activity at the nano-scale\, Lippincott-Schwartz lab has redefined how we look at protein dynamics in the cell. \n\n\n\nThe annual lecture series is set up in the recognition of the development of electron microscopy and will be delivered by eminent scientists in the field of structural biology and molecular visualisation. The event is open to anyone. A holder of the lectureship will particularly spend time with students and postdocs. Therefore\, Jennifer will also give an account of her career path and discuss with students and postdocs at 09.30am in the SciLifeLab Air&Fire auditorium. \n\n\n\nAbout Jennifer Lippincott-Schwartz \n\n\n\nResearch in Lippincott-Schwartz lab is aimed at developing live cell imaging to elucidate the dynamics inside eukaryotic cells. She pioneered photobleaching and photoactivation techniques which allow investigation of subcellular localization\, turnover and trafficking of important cellular proteins related to membrane compartmentalization. Her work on photoactivatable GFP led to the development of one of the first super-resolution imaging technologies\, photoactivation localization microscopy. Jennifer then used her methods to assess organelles dynamics and interactions revealing a novel picture of how the peripheral endoplasmic reticulum is structured. In addition\, the Golgi apparatus is central to Jennifer’s studies\, where her team demonstrated a novel pathway of enzymes recycling important for the organelle’s biogenesis and maintenance. Together\, the obtained findings have provided insights into how genetic diseases affect proteins that help shape the endoplasmic reticulum. \n\n\n\nIn 2016\, Lippincott-Schwartz initiated the Neuronal Cell Biology Program at Janelia. She is Fellow of the American Academy of Arts and Sciences Fellow\, and also Honorary Fellow of the Royal Microscopical Society.  \n\n\n\nBackground information \n\n\n\nThe annual lecture in structural biology is named in honour of Fritiof Sjöstrand\, who pioneered the electron microscopy in Sweden. In the early 1950’s he developed an advanced microtome for thin sectioning\, and by applying it for structural analysis of mitochondria produced a major breakthrough with the determination of the double membrane system. He then engineered a next generation of microtomes using electrical heating of the specimen to advance it toward the knife\, and the instrument became known as the ‘‘Sjöstrand Ultramicrotome”. In 1959\, Fritiof Sjöstrand moved to UCLA\, where his research focused on mitochondrial membranes and retinal synapses. Fritiof Sjöstrand founded and was Editor in Chief of the Journal of Structural Biology for 33 years. Lectures in the previous years were given by Venki Ramakrishnan and Jennifer Doudna. \n\n\n\nContact \n\n\n\nAlexey Amunts\, amunts@scilifelab.se
URL:https://www.scilifelab.se/event/emerging-imaging-technologies-to-study-cell-architecture-dynamics-and-function/
LOCATION:Biomedicum\, Solnavägen 9\, Solna
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211109T100000
DTEND;TZID=Europe/Stockholm:20211109T110000
DTSTAMP:20260405T183836
CREATED:20211102T153126Z
LAST-MODIFIED:20211102T153315Z
UID:10000478-1636452000-1636455600@www.scilifelab.se
SUMMARY:The curious case of a leak channel that never wants to be open
DESCRIPTION:Stephan Pless\, PhD \n\n\n\nProfessor of Molecular and Cellular PharmacologyUniversity of Copenhagen\, Denmark \n\n\n\nThe Pless lab is interested in the molecular function and pharmacology of ion channels. These complex membrane proteins regulate cellular excitability by controlling the flux of ions across cell membranes in response to a diverse set of stimuli. Their dysfunction is associated with numerous diseases\, resulting in an ever-increasing demand for new drugs targeting these fascinating molecules. \n\n\n\n\n\n\n\nDownload
URL:https://www.scilifelab.se/event/the-curious-case-of-a-leak-channel-that-never-wants-to-be-open/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2021/11/Skärmavbild-2021-11-02-kl.-16.27.31.png
ORGANIZER;CN="Molecular Biophysics Stockholm":MAILTO:join-mbp@scilifelab.se.
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211109T150000
DTEND;TZID=Europe/Stockholm:20211109T160000
DTSTAMP:20260405T183836
CREATED:20211101T085537Z
LAST-MODIFIED:20211101T085648Z
UID:10000476-1636470000-1636473600@www.scilifelab.se
SUMMARY:Insights into EMBO’s Fellowship Programme
DESCRIPTION:Kelly Sheehan-Rooney\, Head of the Fellowship Programme at EMBO\, will give an overview of the eligibility and evaluation criteria of EMBO’s Postdoctoral Fellowships\, Scientific Exchange Grants\, and the New Venture Fellowships. She will also give some top tips for grant writing\, and an insight into her career move from academic research to international research development. \n\n\n\nKelly Sheehan-Rooney is Head of the Fellowship Programme at EMBO. She obtained her PhD in Developmental Biology from the University of Manchester\, UK\, before carrying out a three-year postdoctoral position at the University of Texas in Austin\, USA. Now with 10 years’ experience in international research development\, Kelly has worked with thousands of scientists across the world; supporting them in their various careers\, building collaborative networks\, and fostering a research environment where scientists can achieve their best work. \n\n\n\nResearchers in all stages of their career are welcome to attend and could find the talk useful. The fellowships are a great opportunity for early-stage researchers as well as for group leaders to further their research interests and consider new avenues to expand into high quality research ideas. \n\n\n\nMeeting Flyer
URL:https://www.scilifelab.se/event/insights-into-embos-fellowship-programme/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211110T140000
DTEND;TZID=Europe/Stockholm:20211110T150000
DTSTAMP:20260405T183836
CREATED:20211014T151000Z
LAST-MODIFIED:20211020T130718Z
UID:10000466-1636552800-1636556400@www.scilifelab.se
SUMMARY:[Drug Discovery Seminar] How protein degradation led to faculty entrepreneurship at Yale: A personal Perspective
DESCRIPTION:SciLifeLab Drug Discovery Seminars\, hosted by the DDD platform\, is a series of educational lectures about recent developments\, technologies\, and trends in drug discovery and development that aims to enlighten\, and spark a discussion\, within the Swedish drug discovery community. \n\n\n\nCraig Crews\n\n\n\n\n\n\n\n \n\n\n\nJohn C. Malone Professor of Molecular\, Cellular\, and Developmental Biology and Professor of Chemistry\, of Pharmacology\, and of Management; Executive Dirictor\, Yale Center for Molecular Discovery\, Yale University \n\n\n\nAbstract \n\n\n\nProf. Crews is the 2021 recipient of the Scheele prize from the Swedish Pharmaceutical Society for his seminal work on protein degradation. In this talk Prof. Crews will discuss his efforts to translate research from his lab into new biopharma ventures.  To date\, these entrepreneurial  efforts have resulted in a FDA approved drug (Kyprolis) and a new therapeutic modality (PROTACs).  While each of his four companies has been launched based on different science\, they have all followed a similar business model and Prof. Crews will discuss efforts at Yale to ’systematize’ faculty entrepreneurism via a core ‘biotech accelerator’ facility. \n\n\n\nregistration\n\n\n\nBiography \n\n\n\nCrews is the John C. Malone Professor of Molecular\, Cellular and Developmental Biology and holds joint appointments in the departments of Chemistry and Pharmacology at Yale University. He graduated from the U.Virginia with a B.A. in Chemistry and received his Ph.D. from Harvard University in Biochemistry. Dr. Crews has a foothold in both the academic and biotech arenas; on the faculty at Yale since 1995\, his laboratory has pioneered the use of small molecules to control intracellular protein levels.  \n\n\n\nIn 2003\, he co-founded Proteolix\, Inc.\, whose proteasome inhibitor\, Kyprolis™ received FDA approval for the treatment of multiple myeloma. Since Proteolix’s purchase by Onyx Pharmaceuticals in 2009\, Dr. Crews has focused on a new drug development technology\, which served as the founding intellectual property for his latest New Haven-based biotech venture\, Arvinas\, Inc.  \n\n\n\nCurrently\, Dr. Crews serves on several editorial boards and was Editor of Cell Chemical Biology (2008-2018). In addition\, he has received numerous awards and honors\, including the 2013 CURE Entrepreneur of the Year Award\, 2014 Ehrlich Award for Medicinal Chemistry\, 2015 Yale Cancer Center Translational Research Prize\, a NIH R35 Outstanding Investigator Award (2015)\, the AACR Award for Chemistry in Cancer Research (2017)\, Khorana Prize from the Royal Society of Chemistry (2018)\, Pierre Fabre Award for Therapeutic Innovation (2018)\, the Pharmacia-ASPET Award for Experimental Therapeutics (2019)\, the Heinrich Wieland Prize (2020) and the Scheele Prize (2021). In 2019\, he was named an American Cancer Society Professor.
URL:https://www.scilifelab.se/event/drug-discovery-seminar-faculty-entrepreneurship-at-yale-a-personal-perspective/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211112T130000
DTEND;TZID=Europe/Stockholm:20211112T143000
DTSTAMP:20260405T183836
CREATED:20211029T062301Z
LAST-MODIFIED:20211029T062304Z
UID:10000475-1636722000-1636727400@www.scilifelab.se
SUMMARY:Open webinar: How can SciLifeLab\, MAX IV and ESS contribute to drug discovery and development?
DESCRIPTION:During this seminar the three large-scale research infrastructures – SciLifeLab\, MAX IV and ESS – will present their offer to the Life Science industry in form of advanced technologies in the shape of research infrastructure\, as well as relevant data support and structures. Together they can provide technologies ranging from genomics\, proteomics\, genome engineering and drug discovery\, to X-ray beamlines and the most powerful neutron source worldwide. \n\n\n\nThe webinar is a joint venture between Lif and InfraLife\, the initiative that serve as a hubconnecting stakeholders\, displaying the potential of the advanced technologies\, and making these unprecedented tools accessible to be utilized in addressing complex research questions.Who should attend? \n\n\n\nEveryone who works within pharma industry and the Life Science-ecosystem in Sweden and iscurious about what services these three major national infrastructures can offer and how to starta research project. \n\n\n\nRegistration\n\n\n\nPreliminary program: \n\n\n\nWelcomeFrida Lundmark\, Lif \n\n\n\nThe InfraLife projectElin Jonsson and Josefin Lundgren Gawell\, project coordinators InfraLife \n\n\n\nSciLifeLab – possibilities in drug discovery & DevelopmentPer Arvidsson\, Director Drug Discovery & Development platform\, SciLifeLab \n\n\n\nCryo-EM recent development and great possibilities for drug researchMarta Carroni\, Platform Director\, Cell and Molecular Imaging\, SciLifeLab \n\n\n\nThe MAX IV synchrotron and possibilities for Life ScienceSelma Maric\, Industrial Relations\, Life Science and Soft Matter\, MAX IV \n\n\n\nNeutron research possibilities for drug development and the European Spallation Source (ESS)Zoë Fisher\, Group Leader for Deuteration and Macromolecular Crystallisation\, ESS \n\n\n\nIndustry examples from X-ray and neutron experimentsEmanuel Larsson\, Postdoctoral fellow\, Solid Mechanics\, Expert Lunarc (Centre for Scientific and Technological Computing)\, Lund University \n\n\n\nTime for questions \n\n\n\nWrap up and future perspectives
URL:https://www.scilifelab.se/event/open-webinar-how-can-scilifelab-max-iv-and-ess-contribute-to-drug-discovery-and-development/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2020/05/AdobeStock_297709311-scaled.jpeg
ORGANIZER;CN="InfraLife":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211112T140000
DTEND;TZID=Europe/Stockholm:20211112T150000
DTSTAMP:20260405T183836
CREATED:20211014T151650Z
LAST-MODIFIED:20211020T131013Z
UID:10000467-1636725600-1636729200@www.scilifelab.se
SUMMARY:[Drug Discovery Seminar] PROTAC Degraders: From Fundamental Chemical Biology to Translation and Entrepreneurship
DESCRIPTION:SciLifeLab Drug Discovery Seminars\, hosted by the DDD platform\, is a series of educational lectures about recent developments\, technologies\, and trends in drug discovery and development that aims to enlighten\, and spark a discussion\, within the Swedish drug discovery community. \n\n\n\nAlessio Ciulli\n\n\n\nProfessor of Chemical Structural Biology \n\n\n\nCentre for Targeted Protein Degradation\, School of Life Sciences\, Division of Biological Chemistry and Drug Discovery\, University of Dundee \n\n\n\n \n\n\n\nAbstract\n\n\n\nProteolysis-targeting chimeras (PROTACs) are a new class of chemical tools and drugs that target disease-causing proteins for degradation. They are designed to harness the cell’s natural disposal system (the ubiquitin-proteasome) to specifically remove proteins. A PROTAC is a two-headed (i.e. bifunctional) molecule where one end binds an enzyme (an E3 ubiquitin ligase) and the other binds the target protein\, bringing the two proteins into close proximity as a ternary complex. The ligase is then able to label the target protein for ubiquitination and so degradation by the cell’s disposal system. Whereas conventional drugs only inhibit disease proteins by binding and locking up their most important functional parts for the duration of the drug’s action\, PROTACs can bind at any positions and rapidly cause the disease protein’s permanent and long-lasting destruction. Due to this revolutionary mode of action\, PROTACs can attack targets previously thought ‘undruggable’.  \n\n\n\nIn my lecture\, I will outline some key discoveries from my laboratory that have advanced the chemical structural biology of PROTACs\, and are providing fundamental insights into our understanding of their molecular recognition\, mechanism of action and drug design. I will also offer insights from our efforts to translate this fundamental science into molecular therapeutics to benefit patients\, via both partnerships with big pharma and formation of company spin-outs. Finally I will highlight the vision and mission of our recently announced new Centre for Targeted Protein Degradation at Dundee. \n\n\n\nShort Bio\n\n\n\n\n\n\n\nAlessio Ciulli holds the Personal Chair of Chemical Structural Biology at the School of Life Sciences\, University of Dundee. He is also the Director of the newly announced Dundee’s Centre for Targeted Protein Degradation (CeTPD). Dr Ciulli’s laboratory has made important contributions to selective chemical intervention on protein-protein interactions targets and to the development of proteolysis-targeting chimeric molecules (PROTACs) as a viable strategy for targeted protein degradation. Amongst his most significant discoveries are the fragment-based design of ligands for the E3 ligase von Hippel-Lindau (VHL)\, and their use to design one of the first VHL-based PROTACs: the BET degrader MZ1. Dr Ciulli’s Lab later illuminated fundamental insights into PROTACs’ mechanism of action\, solving the first crystal structure of a PROTAC ternary complex. Dr. Ciulli is the scientific founder of Amphista therapeutics\, a company that develops new protein degradation platforms. Before joining Dundee\, Dr Ciulli was a group leader at the University of Cambridge\, where he previously earned his PhD degree. Amongst his honours are the EFMC Prize for Young Medicinal Chemist in Academia\, the RSC Capps Green Zomaya Award in medicinal computational chemistry\, and election as Fellow of the Royal Society of Chemistry. \n\n\n\n \n\n\n\nRegistration
URL:https://www.scilifelab.se/event/drug-discovery-seminar-protac-degraders-from-fundamental-chemical-biology-to-translation-and-entrepreneurship/
LOCATION:Navet\, SciLifeLab Uppsala\, SciLifeLab Uppsala\, BMC C11\, Husargatan 3\, Uppsala\, 75237\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211115T090000
DTEND;TZID=Europe/Stockholm:20211115T093000
DTSTAMP:20260405T183836
CREATED:20211111T133009Z
LAST-MODIFIED:20211111T133419Z
UID:10000489-1636966800-1636968600@www.scilifelab.se
SUMMARY:Meet the BioInnivation Institute
DESCRIPTION:BioInnovation Institute (BII) is an international commercial foundation with a non-profit objective supported by the Novo Nordisk Foundation. BII operates an incubator to accelerate world-class life science innovation that drives the development of new solutions through the creation of life science start-ups for the benefit of people and society. BII offers help to early-stage projects and start-ups in health tech\, bio-industrials and therapeutics through their two programs VentureLab and Creation House.  \n\n\n\nThe programmes are open for applications twice a year. The next application deadlines are November 25th 2021 for Creation House and February 24th 2022 for Venture Lab. \n\n\n\nLearn more about the call on Monday\, November 15\, 09:00.
URL:https://www.scilifelab.se/event/meet-the-bioinnivation-institute/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="External Relations Office":MAILTO:externalrelations@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211122T083000
DTEND;TZID=Europe/Stockholm:20211122T170000
DTSTAMP:20260405T183836
CREATED:20211018T141327Z
LAST-MODIFIED:20211104T080816Z
UID:10000468-1637569800-1637600400@www.scilifelab.se
SUMMARY:DDLS Conference: Strategic research areas - postponed!
DESCRIPTION:Join us at the first conference within The SciLifeLab and Wallenberg national program for Data-Driven Life Science! \n\n\n\n\n\n\n\nThe practice of life science is continuously becoming more data-dependent. The amount and complexity of data is growing exponentially\, and more scientific discoveries are enabled when data is openly available to researchers across the world. This is the basis for the SciLifeLab and Wallenberg National Program on Data-Driven Life Science (DDLS). \n\n\n\nThe program focuses on four strategic areas for data-driven research\, all of which are essential for improving the lives of people as well as animals and nature\, detecting and treating diseases\, protecting biodiversity and creating sustainability:  \n\n\n\nCell and molecular biologyEpidemiology and infection biologyEvolution and biodiversityPrecision medicine and diagnostics\n\n\n\n \n\n\n\nThe conference will focus on enthusing research within the four research areas and aims to bring together researchers within the field for discussion and sharing the latest within the research areas. The meeting will offer an exciting compilation of keynotes\, special lectures within the four fields and opportunities to meet and discuss with prominent researchers.  \n\n\n\nAnyone with interest in the data-driven research field is welcome to participate. The full-day conference will be virtual (Zoom). \n\n\n\n \n\n\n\nThe program with confirmed speakers will be available shortly. \n\n\n\n\n\n\n\nThe conference is part of the SciLifeLab and Wallenberg national program for the DDLS program\, funded by the Alice and Knut Wallenbergs Foundation.
URL:https://www.scilifelab.se/event/ddls-conference-strategic-research-areas/
CATEGORIES:Event
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211122T151500
DTEND;TZID=Europe/Stockholm:20211122T163000
DTSTAMP:20260405T183836
CREATED:20211110T141705Z
LAST-MODIFIED:20211122T105625Z
UID:10000484-1637594100-1637598600@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Prof. Tuuli Lappalainen
DESCRIPTION:Science for Life Laboratory\, Department of Gene Technology\, KTH Royal Institute of Technology\, Stockholm\, Sweden \n\n\n\nNew York Genome Center\, New York\, USA \n\n\n\nLINK TO SEMINAR \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTuuli Lappalainen is a Professor in Genomics at KTH Royal Institute of Technology\, an Associate Faculty Member at the New York Genome Center\, and the Director of the National Genomics Infrastructure of SciLifeLab. She is also an Adjunct Professor at the Department of Systems Biology at Columbia University. \n\n\n\nHer research focuses on functional genetic variation in human populations and its contribution to traits and diseases. She has pioneered the intergration of large-scale genome and transcriptome sequencing data to understand how genetic variation affects gene expression\, providing insight to cellular mechanisms underlying genetic risk for disease. \n\n\n\n\n\n\n\nFunctional variation in the human genome: lessons from the transcriptome\n\n\n\nDetailed characterization of molecular and cellular effects of genetic variants is essential for understanding biological processes that underlie genetic associations to disease. A particularly scalable approach has been linking genetic variants to effects in the transcriptome that is amenable for scalable measurements in human populations and in experimental settings\, including at the single cell level. Our multi-omic analysis in human cohorts in the TOPMed project has identified genetic and environmental effects on molecular variation together with their complex interplay with clinical phenotypes. Furthermore\, in this talk I will discuss how CRISPRi silencing of regulatory elements followed by single-cell analysis provides novel insights of mechanisms of genetic associations to complex traits. Altogether\, these diverse approaches for integration genome and transcriptome data uncover functional genetic architecture of human traits\, and enhances our understanding of both basic biology and precision medicine applications. \n\n\n\nHost: Jessica Nordlund\, Uppsala University
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-prof-tuuli-lappalainen/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211123T100000
DTEND;TZID=Europe/Stockholm:20211123T110000
DTSTAMP:20260405T183836
CREATED:20211110T112711Z
LAST-MODIFIED:20211123T124213Z
UID:10000483-1637661600-1637665200@www.scilifelab.se
SUMMARY:SciLifeLab AI Seminar Series: A sneak peek into the future of AI-assisted life science
DESCRIPTION:SciLifeLab Data Centre hosts a seminar series on the topic of applied AI in life science research. SciLifeLab AI Seminar Series combines scientific highlights from SciLifeLab-affiliated researchers and invited experts on the general topic of AI applications in Life Science.  \n\n\n\nThe seminar will be held physically at SciLifeLab Gamma 7 lunch room in Solna and online via Zoom. Physical participation is recommended since some AI models are not allowed to be shown via streaming and there will be no recording after the seminar according to the live demonstration policy of OpenAI.  \n\n\n\nContact: Prof. Ola Spjuth\, AI coordinator\, SciLifeLab Data Center. \n\n\n\nSpeaker: Wei OUYANGKTH Royal Institute of Technology and Science for Life Laboratory \n\n\n\nAbstract\n\n\n\nHave you imagined how AI may one day help you with your research by proposing new ideas\, running experiments\, analyzing data\, and even writing manuscripts? While current AI systems are too weak for those tasks\, we are closer than ever before! \n\n\n\nIn June 2020\, OpenAI revealed the most advanced AI model in the world\, GPT-3. It is the largest natural language processing model ever created with 175 billion parameters\, trained on about 45TB of text data\, and it cost $12 million for a single training run that may be utilized and reused for many tasks. Not only are these numbers impressive\, its “text in\, text out” interface can be used as a general purpose tool for almost any language task with impressively good performance. With the newly released Codex model (a descendant of GPT-3)\, it can even generate source code in popular programming languages by following instructions in natural languages\, e.g.\, English. GPT-3 not only brings us to a new paradigm of AI-assisted coding\, but it also has a great potential to address long-standing challenges in deep learning about generalization and interpretability. \n\n\n\nWe are excited to share with you what we have learned so far about GPT-3 and its applications in life science. In this talk\, we will give you an overview and discuss the promises and pitfalls of GPT-3. You will also see live demos in biomedical applications\, such as processing genomic sequences\, analyzing microscopy images\, and creating user-friendly software with graphical user interfaces (GUIs). Hopefully\, this session will serve as inspiration for your own research\, serve as a basis for discussion about AI in life science\, and convey how these tools may accelerate data-driven life science at SciLifeLab. \n\n\n\nBiography\n\n\n\nWei OUYANG is a researcher in Prof. Emma Lundberg’s group at the Science for Life Laboratory and KTH Royal Institute of Technology. He has a diverse background across several different fields including material science\, computer science and advanced microscopy imaging. In 2018\, Dr. Ouyang obtained his PhD in computational image analysis at Institut Pasteur\, Paris where he mainly focuses on applying deep learning for super-resolution microscopy. During this period\, he developed a deep learning method called ANNA-PALM which massively accelerates super-resolution localization microscopy by 100x. To address the challenges in the dissemination of AI tools\, he developed an open-source computational platform\, ImJoy\, which makes deep learning tools easier to build and more accessible to the user. He is actively involved in consortiums and community activities for promoting more open\, scalable\, accessible and reproducible scientific tools. Dr Ouyang has been focusing on AI augmented microscopy imaging and data-driven whole cell modeling. More recently\, he is excited about the recent progress in the field of AI and has a knee interest in exploring the next generation of data-driven life science powered by AI\, robotics\, blockchain and decentralized applications. \n\n\n\nRegister here
URL:https://www.scilifelab.se/event/scilifelab-ai-seminar-series-wei-ouyang/
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Data Centre":MAILTO:datacentre@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211126T090000
DTEND;TZID=Europe/Stockholm:20211126T093000
DTSTAMP:20260405T183836
CREATED:20211014T115823Z
LAST-MODIFIED:20211014T120713Z
UID:10000465-1637917200-1637919000@www.scilifelab.se
SUMMARY:Clinical Talks: The road towards precision medicine in Sweden
DESCRIPTION:On November 26\, we will host Karolinska Institutet (KI) Professor Richard Rosenquist Brandell. In addition to his academic research and clinical work\, he also co-founded the Genomic Medicine Sweden (GMS) initiative and serves as the Director of GMS. Richard will share his insights on Sweden’s national strategy to implement precision medicine into our healthcare environment and pave the way for the amazing potential the approach has to offer. To benefit from the sustainable advantages of tailored and efficient use of diagnostics and treatment options\, Sweden needs to prepare our society for the legal challenges and infrastructures necessary to support and enable this transformation. \n\n\n\nRead more about clinical talks\n\n\n\nRichard Rosenquist Brandell\, MD\, PhD\, is Professor of Clinical Genetics at Karolinska Institutet\, Senior Physician at Karolinska University Hospital and director of Genomic Medicine Sweden\, a national infrastructure for implementation of precision medicine. He obtained his MD degree in 1996\, and later his PhD in Medicine in 1998\, from Umeå University. In 2000 Richard joined Uppsala University Hospital (“Akademiska Sjukhuset”) and in 2007 became a Professor at the Department of Immunology\, Genetics and Pathology\, Uppsala University. In April 2017\, he relocated to the Karolinska University Hospital as a Senior Physician and Professor. Richard’s work focuses on hematological malignancies and utilizing high-throughput sequencing technologies\, his team has identified novel prognostic and predictive biomarkers that have significantly improved patient risk-stratification.  Dr Rosenquist Brandell is also a member of the Nobel Assembly at Karolinska Institutet. \n\n\n\nGenomic Medicine Sweden (GMS) started as a bottom-up initiative within the national Clinical Genomics Platform (previously named the Diagnostics Development platform) at the Swedish Science for Life Laboratory (SciLifeLab). In 2017 and 2018 discussions with funding agencies\, decision-makers\, healthcare providers\, patient organisations\, universities\, and industry led to the founding of GMS as a national venture. GMS strategic mission is to foster collaboration between healthcare providers\, academia\, patient organizations and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden. \n\n\n\nRegistration
URL:https://www.scilifelab.se/event/clinical-talks-the-road-towards-precision-medicine-in-sweden/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/09/ClinicalTalks_Season5_twitter_1024.jpg
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211130T103000
DTEND;TZID=Europe/Stockholm:20211201T150000
DTSTAMP:20260405T183836
CREATED:20210819T073949Z
LAST-MODIFIED:20211109T082852Z
UID:10000408-1638268200-1638370800@www.scilifelab.se
SUMMARY:Swedish Microfluidics in Life Science 2021
DESCRIPTION:The Swedish Microfluidics in Life Science meeting gathers researchers in the field of micro- and nanofluidics. The meeting offers an opportunity to present your research\, to network with researchers at Swedish universities\, institutes and companies \, and to listen to invited talks by a panel of well reputed research leaders. Confirmed speakers are Stefan Löfås (Innovido AB)\, Edith Hammer (Lund University)\, Christoph Merten (Ecole Polytechnique Fédérale de Lausanne)\, Anja Boisen (‎Technical University of Denmark) and Madhavi Krishnan (University of Oxford) \n\n\n\nSave the date and please help spread this information in your groups and local networks. \n\n\n\nRead more
URL:https://www.scilifelab.se/event/swedish-microfluidics-in-life-science-2021/
LOCATION:Lund University\, Lund\, Sweden
CATEGORIES:Event
ORGANIZER;CN="Swedish Microfluidics in Life Sciences":MAILTO:per.augustsson@bme.lth.se
END:VEVENT
END:VCALENDAR